Evidence map›Paper›PMID 38798496›Full record

ArticlebioRxiv : the preprint server for biology2024

IFDlong: an isoform and fusion detector for accurate annotation and quantification of long-read RNA-seq data.

Wenjia Wang, Yuzhen Li, Sungjin Ko, Ning Feng, Manling Zhang, Jia-Jun Liu, Songyang Zheng, Baoguo Ren, Yan P Yu, Jian-Hua Luo and 2 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Wenjia WangDepartment of Biostatistics, School of Public Health, University of Pittsburgh, Pittsburgh, PA.
Yuzhen LiDepartment of Surgery, School of Medicine, University of Pittsburgh, Pittsburgh, PA.
Sungjin KoDepartment of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA.
Ning FengDepartment of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA.
Manling ZhangDepartment of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA.
Jia-Jun LiuDepartment of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA.
Songyang ZhengDepartment of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA.
Baoguo RenDepartment of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA.
Yan P YuDepartment of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA.
Jian-Hua LuoDepartment of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA.
George C TsengDepartment of Biostatistics, School of Public Health, University of Pittsburgh, Pittsburgh, PA.
Silvia LiuDepartment of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0002-1840-9520

Funding

University of Pittsburgh Clinical and Translational Science InstituteUL1TR001857 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2016 to 2025
$129.3M
Pittsburgh Liver Research CenterP30DK120531 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Shuchang Silvia Liu · 2019 to 2026
$10.9M
Identifying therapeutic options for intrahepatic cholangiocarcinomaR01CA258449 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KO, SUNGJIN · 2021 to 2025
$1.6M
High-Throughput Computing for Genomics and Bioinformatics ResearchS10OD028483 · OD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEE, ADRIAN V · 2021 to 2021
$574k
NCATS NIH HHS UL1 TR001857NCI NIH HHS R01 CA258449NIDDK NIH HHS P30 DK120531NIH HHS S10 OD028483
6 · The paper itself

Abstract

Advancements in long-read transcriptome sequencing (long-RNA-seq) technology have revolutionized the study of isoform diversity. These full-length transcripts enhance the detection of various transcriptome structural variations, including novel isoforms, alternative splicing events, and fusion transcripts. By shifting the open reading frame or altering gene expressions, studies have proved that these transcript alterations can serve as crucial biomarkers for disease diagnosis and therapeutic targets. In this project, we proposed IFDlong, a bioinformatics and biostatistics tool to detect isoform and fusion transcripts using bulk or single-cell long-RNA-seq data. Specifically, the software performed gene and isoform annotation for each long-read, defined novel isoforms, quantified isoform expression by a novel expectation-maximization algorithm, and profiled the fusion transcripts. For evaluation, IFDlong pipeline achieved overall the best performance when compared with several existing tools in large-scale simulation studies. In both isoform and fusion transcript quantification, IFDlong is able to reach more than 0.8 Spearman's correlation with the truth, and more than 0.9 cosine similarity when distinguishing multiple alternative splicing events. In novel isoform simulation, IFDlong can successfully balance the sensitivity (higher than 90%) and specificity (higher than 90%). Furthermore, IFDlong has proved its accuracy and robustness in diverse in-house and public datasets on healthy tissues, cell lines and multiple types of diseases. Besides bulk long-RNA-seq, IFDlong pipeline has proved its compatibility to single-cell long-RNA-seq data. This new software may hold promise for significant impact on long-read transcriptome analysis. The IFDlong software is available at https://github.com/wenjiaking/IFDlong.

Indexed as

alternative splicingfusion transcriptisoformLong read sequencingsingle-cell sequencingtranscriptome sequencing

Identifiers

PMID38798496
PMCPMC11118288

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.